Market Recap Check: Avadel Pharmaceuticals plc (AVDL)’s Positive Finish at 16.81, Up/Down 1.76

Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.

The price of Avadel Pharmaceuticals plc (NASDAQ: AVDL) closed at $16.81 in the last session, up 1.76% from day before closing price of $16.52. In other words, the price has increased by $1.76 from its previous closing price. On the day, 0.96 million shares were traded. AVDL stock price reached its highest trading level at $17.5 during the session, while it also had its lowest trading level at $16.55.


We take a closer look at AVDL’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.60 and its Current Ratio is at 2.85. In the meantime, Its Debt-to-Equity ratio is 0.47 whereas as Long-Term Debt/Eq ratio is at 0.46.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on March 05, 2024, Reiterated its Outperform rating but revised its target price to $29 from $27 previously.

On March 05, 2024, Needham reiterated its Buy rating and also lowered its target price recommendation from $20 to $22.

H.C. Wainwright reiterated its Buy rating for the stock on March 05, 2024, while the target price for the stock was revised from $21 to $25.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 16 ’24 when MCHUGH THOMAS S bought 2,000 shares for $14.50 per share. The transaction valued at 29,000 led to the insider holds 80,500 shares of the business.

McCamish Mark Anthony sold 75,000 shares of AVDL for $1,089,750 on Dec 28 ’23. The Director now owns 67,025 shares after completing the transaction at $14.53 per share. On Aug 14 ’23, another insider, MCHUGH THOMAS S, who serves as the Chief Financial Officer of the company, bought 2,000 shares for $14.45 each. As a result, the insider paid 28,900 and bolstered with 78,500 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVDL now has a Market Capitalization of 1615751808 and an Enterprise Value of 1577014784. For the stock, the TTM Price-to-Sale (P/S) ratio is 29.30 while its Price-to-Book (P/B) ratio in mrq is 20.61. Its current Enterprise Value per Revenue stands at 56.396 whereas that against EBITDA is -11.589.

Stock Price History:

The Beta on a monthly basis for AVDL is 1.77, which has changed by 0.14744031 over the last 52 weeks, in comparison to a change of 0.2704494 over the same period for the S&P500. Over the past 52 weeks, AVDL has reached a high of $19.09, while it has fallen to a 52-week low of $9.50. The 50-Day Moving Average of the stock is -0.12%, while the 200-Day Moving Average is calculated to be 21.81%.

Shares Statistics:

According to the various share statistics, AVDL traded on average about 1.27M shares per day over the past 3-months and 1529430 shares per day over the past 10 days. A total of 89.83M shares are outstanding, with a floating share count of 85.15M. Insiders hold about 11.41% of the company’s shares, while institutions hold 51.71% stake in the company. Shares short for AVDL as of 1713139200 were 10613205 with a Short Ratio of 3.78, compared to 1710460800 on 10474142. Therefore, it implies a Short% of Shares Outstanding of 10613205 and a Short% of Float of 12.6.

Most Popular

[the_ad id="945"]